covid 19 News and Research

RSS

Enhanced neutralizing antibody and T-cell responses by DNA-based vaccine encoding SARS-CoV-2 spike protein

Researchers from VaxiGen have been investigating the potential for a DNA vaccine boost to VP vaccines against coronavirus disease 2019.

9 Nov 2021

COVID-19 drug candidate with wide-ranging antiviral activity

A new study investigated the antiviral activity and mechanism of action of Brilacidin against multiple human coronaviruses.

9 Nov 2021

Invalidation of potential SARS-CoV-2 protease inhibitors

Researchers identified several structurally disparate compounds that can inhibit the viral protease PLpro and determined whether the identified PLpro inhibitors are truly effective and should be further investigated.

9 Nov 2021

CN Bio and iiCON announce COVID-19 research collaboration

CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single- and multi-organ microphysiological systems (MPS), today announced a research collaboration with the Infection Innovation Consortium (iiCON), a global collaborative infectious disease R&D programme, to validate the next generation of COVID-19 research tools.

From CN-Bio 9 Nov 2021

Non-invasive breathing support to treat COVID-19 does not pose higher risk of infection

New research has found that the use of non-invasive breathing support to treat moderate to severe COVID-19 infection, isn’t linked to a heightened infection risk, as currently thought.

9 Nov 2021

New campaign shows how prediabetes can be reversed

Prediabetes can be reversed – and the American Medical Association, the Centers for Disease Control and Prevention, and the Ad Council want people to know it.

9 Nov 2021

Hiding face movements with a mask can affect our ability to socially interact with others

Study finds blocking or hiding facial movement can affect sharing of emotions and social interaction

9 Nov 2021

Pfizer-BioNTech COVID-19 vaccine is associated with lower viral load in breakthrough infections

Several vaccines have been rapidly developed to help control the COVID-19 pandemic, including the BNT162b2 vaccine (Pfizer/BioNTech). This severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine has been shown in both clinical trials and in the real world to be highly efficacious in preventing infection, symptoms, hospitalizations, severe disease, and death related to coronavirus disease (COVID-19).

9 Nov 2021

CDC study shows COVID-19 in newborns is rare

To date, there have been relatively few cases of neonates with COVID-19, and there is limited knowledge of neonatal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, recent studies have suggested an increased risk of severe COVID-19 in infants compared to older children, which is based on data that shows an increased rate of hospitalization among infants.

9 Nov 2021

Drinking alcohol and not exercising are modifiable risk factors for SARS-CoV-2

New research from the United Kingdom suggests several factors that increased the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection involved higher alcohol use, Asian/Asian British ethnicity, and obesity. In addition, moderate but not vigorous exercise of more than 10 hours a week was associated with lower susceptibility to infection.

8 Nov 2021

Increase in SARS-CoV-2 seroprevalence in Irish HCWs during third wave of pandemic

Healthcare workers and people they live with are at an increased risk of contracting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Hospital healthcare workers (HCWs) worldwide have been found to have a higher number of SARS-CoV-2 infections and higher antibody seroprevalence compared to the general population.

8 Nov 2021

Scientists develop a high-throughput, cell-free screening platform for anti-SARS-CoV-2 antibody discovery

Scientists from Northwestern University, USA, have recently developed a high-throughput, automated screening platform to rapidly identify anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies. The study is currently available on the bioRxiv* preprint server.

8 Nov 2021

Study reveals cellular mechanism behind older adults' susceptibility to COVID-19

Among the populations most significantly affected by COVID-19 are the elderly and patients with preexisting medical conditions including diabetes, hypertension, obesity, metabolic syndrome, cardiovascular disease and chronic lung diseases like COPD and asthma.

8 Nov 2021

Lack of health insurance accounts for unemployed adults' lower cancer screening rates

In a recent study, unemployed individuals were less likely to have health insurance and be up to date on getting recommended cancer screening tests.

8 Nov 2021

High sitting time may increase depressive symptoms and anxiety

As people adhered to stay-at-home orders or self-isolated during the early months of the COVID-19 outbreak, daily commutes turned into shuffles between the bedroom and the living room. Clicking Zoom links erased time spent walking to meeting rooms, and Netflix spilled into time otherwise dedicated to the gym.

8 Nov 2021

covid 19 News and Research

Enhanced neutralizing antibody and T-cell responses by DNA-based vaccine encoding SARS-CoV-2 spike protein

COVID-19 drug candidate with wide-ranging antiviral activity

Invalidation of potential SARS-CoV-2 protease inhibitors

CN Bio and iiCON announce COVID-19 research collaboration

Non-invasive breathing support to treat COVID-19 does not pose higher risk of infection

New campaign shows how prediabetes can be reversed

Hiding face movements with a mask can affect our ability to socially interact with others

Pfizer-BioNTech COVID-19 vaccine is associated with lower viral load in breakthrough infections

CDC study shows COVID-19 in newborns is rare

Drinking alcohol and not exercising are modifiable risk factors for SARS-CoV-2

Increase in SARS-CoV-2 seroprevalence in Irish HCWs during third wave of pandemic

Scientists develop a high-throughput, cell-free screening platform for anti-SARS-CoV-2 antibody discovery

Study reveals cellular mechanism behind older adults' susceptibility to COVID-19

Lack of health insurance accounts for unemployed adults' lower cancer screening rates

High sitting time may increase depressive symptoms and anxiety

COVID-19 lockdowns and young people's mental health

Discovery of potent neutralizing antibodies against SARS-CoV-2 variants

Hemin as a potential therapy for COVID-19

SARS-CoV-2 Nsp1 deletions affect protein stability and translation inhibition

Study compares efficacy of BNT162b2 and CoronaVac as the booster dose for COVID-19 vaccination

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News